Literature DB >> 12788079

TNF-alpha and leptin activate the alpha-isoform of class II phosphoinositide 3-kinase.

C Ktori1, P R Shepherd, L O'Rourke.   

Abstract

The class II PI 3-kinases are known to be activated by growth factors and chemokines but to date there are no reports of cytokine mediated regulation. Further, the intracellular signalling mechanisms regulating the class-II PI 3-kinases are poorly understood. We investigated the effects of the cytokines TNFalpha and leptin on the activity of the alpha isoform of the class II PI 3-kinase (PI3K-C2alpha) and find that these stimulate the enzyme 2-fold and 3-fold, in CHO cells and J774.2 macrophages, respectively. The stimulation by leptin was not accompanied by recruitment of any tyrosine phosphorylated proteins to PI3K-C2alpha and no shift in electrophoretic mobility was noted. Furthermore, we demonstrate that the actions of both cytokines are blocked by the MEK inhibitor PD98059. These findings indicate that the cytokines activate PI3K-C2alpha and do so by a mechanism that requires activation of the ERK pathway and thus differs from the mechanism used by insulin to activate the enzyme.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788079     DOI: 10.1016/s0006-291x(03)00933-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Requirement for class II phosphoinositide 3-kinase C2alpha in maintenance of glomerular structure and function.

Authors:  David P Harris; Peter Vogel; Marie Wims; Karen Moberg; Juliane Humphries; Kanchan G Jhaver; Christopher M DaCosta; Melanie K Shadoan; Nianhua Xu; Gwenn M Hansen; Sanjeevi Balakrishnan; Jan Domin; David R Powell; Tamas Oravecz
Journal:  Mol Cell Biol       Date:  2010-10-25       Impact factor: 4.272

2.  Targeting PI3K in Cancer: Any Good News?

Authors:  Miriam Martini; Elisa Ciraolo; Federico Gulluni; Emilio Hirsch
Journal:  Front Oncol       Date:  2013-05-08       Impact factor: 6.244

3.  Endosomal Phosphatidylinositol 3-Phosphate Promotes Gephyrin Clustering and GABAergic Neurotransmission at Inhibitory Postsynapses.

Authors:  Theofilos Papadopoulos; Hong Jun Rhee; Devaraj Subramanian; Foteini Paraskevopoulou; Rainer Mueller; Carsten Schultz; Nils Brose; Jeong-Seop Rhee; Heinrich Betz
Journal:  J Biol Chem       Date:  2016-12-09       Impact factor: 5.157

4.  Leptin regulation of proangiogenic molecules in benign and cancerous endometrial cells.

Authors:  Cecilia Carino; Alexander B Olawaiye; Salandre Cherfils; Takehiro Serikawa; Maureen P Lynch; Bo R Rueda; Ruben R Gonzalez
Journal:  Int J Cancer       Date:  2008-12-15       Impact factor: 7.396

Review 5.  Phosphoinositides: tiny lipids with giant impact on cell regulation.

Authors:  Tamas Balla
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

6.  The role of collybistin in gephyrin clustering at inhibitory synapses: facts and open questions.

Authors:  Theofilos Papadopoulos; Tolga Soykan
Journal:  Front Cell Neurosci       Date:  2011-06-24       Impact factor: 5.505

7.  Evolutionary history of phosphatidylinositol- 3-kinases: ancestral origin in eukaryotes and complex duplication patterns.

Authors:  Héloïse Philippon; Céline Brochier-Armanet; Guy Perrière
Journal:  BMC Evol Biol       Date:  2015-10-19       Impact factor: 3.260

Review 8.  Microglia Mediated Neuroinflammation: Focus on PI3K Modulation.

Authors:  Antonia Cianciulli; Chiara Porro; Rosa Calvello; Teresa Trotta; Dario Domenico Lofrumento; Maria Antonietta Panaro
Journal:  Biomolecules       Date:  2020-01-14

9.  Crystal structures of PI3K-C2alpha PX domain indicate conformational change associated with ligand binding.

Authors:  Gary N Parkinson; David Vines; Paul C Driscoll; Snezana Djordjevic
Journal:  BMC Struct Biol       Date:  2008-02-29

10.  Inactivation of class II PI3K-C2α induces leptin resistance, age-dependent insulin resistance and obesity in male mice.

Authors:  Samira Alliouachene; Benoit Bilanges; Claire Chaussade; Wayne Pearce; Lazaros C Foukas; Cheryl L Scudamore; Larissa S Moniz; Bart Vanhaesebroeck
Journal:  Diabetologia       Date:  2016-04-30       Impact factor: 10.122

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.